ARL5B and esophageal squamous cell carcinoma: Collectively, these multiplatform investigations integrating bioinformatic prediction with histological validation, cellular characterization, and clinical correlation systematically establish ARL5B as a pathologically upregulated molecule in ESCC, providing critical foundation for subsequent mechanistic inquiries.